Cargando…
Counting the neurological cost of COVID-19
The neurological deficits caused by COVID-19, which were first reported in the early months of 2020, continue to intrigue neurologists and health-care professionals worldwide. As two new studies highlight, these manifestations are frequent and are expected to increase the burden of morbidity and mor...
Autor principal: | Baig, Abdul Mannan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600497/ https://www.ncbi.nlm.nih.gov/pubmed/34795449 http://dx.doi.org/10.1038/s41582-021-00593-7 |
Ejemplares similares
-
Risk–benefit analysis of COVID-19 vaccines — a neurological perspective
por: Lau, Colleen L., et al.
Publicado: (2021) -
Looking for lights in the fog of long-term neurological COVID
por: Padovani, Alessandro, et al.
Publicado: (2022) -
Neurological manifestations in COVID‐19 caused by SARS‐CoV‐2
por: Baig, Abdul Mannan
Publicado: (2020) -
Chronic long‐COVID syndrome: A protracted COVID‐19 illness with neurological dysfunctions
por: Baig, Abdul Mannan
Publicado: (2021) -
Differential diagnosis and pathogenesis of the neurological signs and symptoms in COVID‐19 and long‐COVID syndrome
por: Baig, Abdul Mannan
Publicado: (2022)